Management of Uncontrolled Hyperglycemia

Assessment and Immediate Management

The American Diabetes Association recommends considering insulin therapy for patients with blood sugar levels of 300 mg/dL or higher, indicating severe hyperglycemia requiring immediate intervention 1
Dual therapy with metformin and glipizide is insufficient to achieve glycemic control in patients with severe hyperglycemia, suggesting significant insulin deficiency and/or insulin resistance 1
The American Diabetes Association suggests that this level of hyperglycemia requires more potent glucose-lowering intervention, such as insulin therapy or the addition of a GLP-1 receptor agonist or SGLT2 inhibitor 1, 3

The American Diabetes Association recommends adding a GLP-1 receptor agonist or SGLT2 inhibitor with demonstrated cardiovascular benefit as part of the glucose-lowering regimen for patients with uncontrolled hyperglycemia 1
GLP-1 receptor agonists offer additional benefits over insulin and sulfonylureas, including lower risk of hypoglycemia, favorable weight effects, and cardiovascular benefits 1

The American College of Endocrinology recommends implementing home blood glucose monitoring with frequent checks for patients with uncontrolled hyperglycemia 5
Regular HbA1c monitoring every 3 months is recommended to assess long-term glycemic control, according to the American Diabetes Association 5

Once glucose toxicity resolves and glycemic control improves, the American Diabetes Association suggests considering simplifying the medication regimen 1
The American Association of Clinical Endocrinologists recommends evaluating for diabetes complications and providing appropriate preventive care for patients with uncontrolled hyperglycemia 5